| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Sep 3, 2024 | Sep 5, 2024 | Athira Pharma, Inc. | COO | Sell | 90.0 | +7,475 | 55.80% | ✗ | $1.4K |
| Jan 4, 2024 | Feb 16, 2024 | Athira Pharma, Inc. | COO | Sell | 90.0 | +7,588 | 130.67% | ✗ | $7K |
| Jan 4, 2024 | Jan 8, 2024 | Athira Pharma, Inc. | COO | Sell | 90.0 | +7,588 | 130.67% | ✗ | $7K |
| Jun 22, 2022 | Jun 24, 2022 | Athira Pharma, Inc. | COO | Sell | 91.3 | +5,807 | 100.00% | ✗ | $11.3K |